New York Blood Center Inc

New York Blood Center Inc: 4 recalls listed since February 2026 across FDA; 4 ended.

By year

Apheresis Platelets, Leukocytes Reduced had a platelet count higher than acceptable.

Moderate riskFDASep 24, 2026Quality testing problem

Red Blood Cells, Leukocytes Reduced were collected from a donor previously deferred for hepatitis C antibody testing.

Moderate riskFDAAug 13, 2026Contamination

The products were collected from a donor who previously tested reactive for the antibody to Hepatitis B core antigen on more than one occasion.

Moderate riskFDAJun 24, 2026Blood donor screening

Apheresis Platelets, Leukocytes Reduced did not meet platelet yield specifications.

Moderate riskFDAFeb 13, 2026Quality testing problem